Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease collagen disease
Phenotype C0020538|hypertension
Sentences 49
PubMedID- 20919946 Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease.
PubMedID- 25215642 Treatment of hypertension in patients with rheumatic diseases.
PubMedID- 26022952 Patients with pulmonary arterial hypertension associated with connective tissue disease had significantly poorer survival rates compared to other aetiologies (p<0.003).the favourable short-term haemodynamic results and good survival rates, observed in patients receiving both bosentan and sildenafil, supports the use of sequential combination therapy in patients failing on monotherapy in a real-world setting.
PubMedID- 22748903 Pulmonary arterial hypertension in connective tissue diseases.
PubMedID- 23083052 Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the korean registry.
PubMedID- 25129118 [pulmonary arterial hypertension associated with connective tissue diseases].
PubMedID- 21676917 The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
PubMedID- 24088343 Pulmonary angiography was conducted, and when no clot was discovered, pulmonary artery hypertension associated with connective tissue disease was considered.
PubMedID- 26155616 [clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class iv) pulmonary arterial hypertension associated with diffuse connective tissue diseases].
PubMedID- 22015567 Pulmonary arterial hypertension in connective tissue diseases.
PubMedID- 21165350 Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease.
PubMedID- 24400542 Pulmonary hypertension associated with connective tissue diseases].
PubMedID- 25076987 The second part, however, is more extensive and targets certain groups/diseases of ph, such as connective tissue disease associated with pulmonary arterial hypertension (ctd-apah), hemolytic anemia associated with ph, portopulmonary arterial hypertension, congenital heart diseases (chd)-apah, chronic thromboembolic pulmonary hypertension (cteph), and creating detailed review articles.
PubMedID- 21873802 Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease.
PubMedID- 23334373 Pulmonary arterial hypertension (pah) associated with rheumatic diseases carries a particularly grim prognosis with faster progression of disease and poor response to therapy.
PubMedID- 25818118 Associations between sildenafil use and changes in days of hospitalization in a population with pulmonary arterial hypertension associated with connective tissue disease.
PubMedID- 23732415 Results: the most common connective tissue disease associated with pulmonary arterial hypertension was diffuse scleroderma in 46% of cases.
PubMedID- 25877137 [the more particular clinical classification of connective tissue diseases with pulmonary arterial hypertension, the more precise choice of therapy].
PubMedID- 23906950 Pulmonary arterial hypertension associated with connective tissue disease: meta-analysis of clinical trials.
PubMedID- 20847509 Idiopathic portal hypertension in a patient with mixed connective tissue disease and protein c deficiency.
PubMedID- 25748129 [management of borderline pulmonary arterial hypertension associated with connective tissue diseases].
PubMedID- 22884388 The importance of pvod as the basis of pulmonary hypertension in patients with connective tissue disease has been recently proposed, as well as the role of thrombogenesis, in the development of pvod.
PubMedID- 25026800 [bosentan: a considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases].
PubMedID- 20375662 Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease.
PubMedID- 24822109 Objective: to investigate the prevalence of anti-endothelial cell antibodies (aeca) in connective tissue diseases (ctd) associated with pulmonary arterial hypertension (pah) and to corroborate the pathologic function of aeca in pah-associated ctds.
PubMedID- 22354598 No cases of serous retinal or choroidal detachment were observed in either eye in any treatment group at baseline, but both conditions were detected at week 12 in the left eye of one participant with pulmonary arterial hypertension associated with connective tissue disease in the sildenafil 40 mg group (incidence for each=2%).
PubMedID- 20449950 Prevalence of anti-endothelial cell antibodies in patients with pulmonary arterial hypertension associated with connective tissue diseases.
PubMedID- 23154245 Furthermore, we emphasize that cardiac catheterization played a critical role in the differential diagnosis from pulmonary hypertension associated with connective tissue disease.
PubMedID- 21963571 Pulmonary arterial hypertension associated with connective tissue disease and immunosuppressive therapy.
PubMedID- 21918364 A histopathological study of pulmonary hypertension in connective tissue disease.
PubMedID- 20597269 [arterial hypertension in patients with systemic connective tissue diseases and hemorrhagic vasculitis].
PubMedID- 23686514 Rapid progression to pulmonary arterial hypertension crisis associated with mixed connective tissue disease in an 11-year-old girl.
PubMedID- 22720870 ¶:p < 0.05 in comparison to group 2, pulmonary arterial hypertension associated with connective tissue disease (pah-ctd).
PubMedID- 22589263 Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.
PubMedID- 26425039 Recently, the registry of pulmonary hypertension associated with rheumatic disease (reopard), a nationwide, multicenter, observational korean registry, reported that korean ctd-pah patents exhibit some differences with respect to underlying diseases, functional status and treatment compared with western country registries (1718).
PubMedID- 25960979 (2011) demonstrated the benefits of exercise training in a connective tissue disease population with pulmonary hypertension (grunig et al., 2012b).
PubMedID- 22621693 Treatment of pulmonary arterial hypertension in connective tissue disease.
PubMedID- 21212140 Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases.
PubMedID- 21211937 Pulmonary veno-occlusive disease: the bete noire of pulmonary hypertension in connective tissue diseases.
PubMedID- 20160534 Pulmonary arterial hypertension in connective tissue diseases.
PubMedID- 23359006 Objective: to assess the efficacy of epoprostenol treatment in japanese patients with pulmonary arterial hypertension (pah) associated with connective tissue disease (ctd).
PubMedID- 25736353 Left heart abnormalities in connective tissue disease patients with pre-capillary pulmonary hypertension as well as borderline mean pulmonary arterial pressure.
PubMedID- 22137255 Methods: forty-eight patients (mean age, 41.3 +/- 11.6 years; 91.7% women) with pulmonary arterial hypertension associated with connective tissue diseases who underwent right-heart catheterization and acute pulmonary vasodilator testing were prospectively recruited.
PubMedID- 23780636 The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the uncover study).
PubMedID- 23555874 First, we performed a logistic regression analysis that excluded women with any medical complications (hypothyroidism, hyperthyroidism, asthma, heart disease, collagen disease, preexisting hypertension and diabetes), gestational diabetes mellitus and hypertensive disorders in pregnancy.
PubMedID- 22205898 Associated pulmonary arterial hypertension in connective tissue diseases.
PubMedID- 22872790 The pivotal subcutaneous treprostinil trial by simmoneau et al in 2002 enrolled 470 patients at 24 us centers and 16 international sites with pah, either primary pulmonary hypertension, that associated with connective tissue disease or congenital systemic-to-pulmonary shunts in a 12-week, double-blind, placebo-controlled trial.
PubMedID- 22709477 Exercise training in pulmonary arterial hypertension associated with connective tissue diseases.
PubMedID- 25214713 Effect of th17 and treg axis disorder on outcomes of pulmonary arterial hypertension in connective tissue diseases.

Page: 1